In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Scientific gets Embol-X' s technology

Executive Summary

Boston Scientific (interventional medical devices) has acquired Embol-X's (embolic protection) assets and intellectual property relating to percutaneous application of embolic protection devices for use in minimally invasive interventional procedures. BS will also take a 10% equity interest in Embol-X.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Product Purchase
    • R&D and Marketing (Licensing)

Related Companies